Lars Ekblad (Former)
21 – 30 of 38
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Autocrine epidermal growth factor receptor ligand production and cetuximab response in head and neck squamous cell carcinoma cell lines.
(
- Contribution to journal › Article
-
Mark
The anti-tumour effect of cisplatin and ifosfamide on xenografted squamous cell carcinoma of the head and neck is schedule-dependent.
(
- Contribution to journal › Article
-
Mark
Cetuximab sensitivity associated with oxaliplatin resistance in colorectal cancer.
(
- Contribution to journal › Article
- 2011
-
Mark
Coomassie Staining as Loading Control in Western Blot Analysis
(
- Contribution to journal › Article
- 2010
-
Mark
Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells.
(
- Contribution to journal › Article
- 2009
-
Mark
Early changes in 2-deoxy-2-[18F]fluoro-D-glucose metabolism in squamous-cell carcinoma during chemotherapy in vivo and in vitro.
(
- Contribution to journal › Article
-
Mark
Epidermal growth factor receptor status and persistent activation of Akt and p44/42 MAPK pathways correlate with the effect of cetuximab in head and neck and colon cancer cell lines.
(
- Contribution to journal › Article
-
Mark
No direct effects of erythropoietin beta on a head and neck squamous cell carcinoma cell line which is growth stimulated in vivo.
(
- Contribution to journal › Article
- 2007
-
Mark
In-Source Decay Causes Artifacts in SELDI-TOF MS Spectra.
(
- Contribution to journal › Article
-
Mark
Regression analysis and modelling of data acquisition for SELDI-TOF mass spectrometry.
(
- Contribution to journal › Article